Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01784822 · ClinicalTrials.gov registry record
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
A clinical trial of Ventral Hernias, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- 63
- Enrollment target
- 5
- Study locations
NCT01784822 is a study of Ventral Hernias that has completed, run by Cook Group Incorporated. The registered enrollment target is 63 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT01784822, a study of Ventral Hernias, has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objective this study is to collect post-market data on the performance of the Zenapro™ Hybrid Hernia Repair Device when used to reinforce or bridge the abdominal wall for the repair of ventral hernias.
Conditions Studied
Interventions
- DEVICE Zenapro™ Hybrid Hernia Repair Device
Study Locations (5)
North Carolina
- Duke University - Durham
Ohio
- Cleveland Clinic - Cleveland
Pennsylvania
- Penn State Milton S. Hershey Medical Center - Hershey
Tennessee
- University of Tennessee - Knoxville
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01784822
The ClinicalTrials.gov registry entry for NCT01784822 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ventral Hernias appearing as the primary indexed condition, and to 1 intervention - of which Zenapro™ Hybrid Hernia Repair Device is the first listed.
NCT01784822 reports 5 study locations spanning 5 distinct geographic areas - top geographies include North Carolina, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01784822 about?
NCT01784822 is a clinical study titled "Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair". The objective this study is to collect post-market data on the performance of the Zenapro™ Hybrid Hernia Repair Device when used to reinforce or bridge the abdominal wall for the repair of ventral hernias.
What is the current status of trial NCT01784822?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2013-02. Estimated completion is 2016-06.
What conditions does trial NCT01784822 study?
This clinical trial studies the following conditions: Ventral Hernias.
What interventions are being tested in trial NCT01784822?
The interventions under investigation include: Zenapro™ Hybrid Hernia Repair Device (DEVICE).
Who is sponsoring clinical trial NCT01784822?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01784822 being conducted?
This trial has 5 study locations across North Carolina, Ohio, Pennsylvania, Tennessee, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.